alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 16,826–16,850 of 27,380 studies, newest first · page 674 of 1096.

July 2015 25

  1. 2015-07-07

    Reelin protects against amyloid β toxicity in vivo

    ✓ Peer-reviewed Disease mechanisms Science signaling

    Key finding: We have previously shown that the presence of ApoE4 renders neurons unresponsive to Reelin by impairing the recycling of the receptors, thereby decreasing its protective effects against amyloid β (Aβ) oligomer-induced synaptic toxicity in vitro. +2 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2015-07-03

    Olfactory identification deficits and increased mortality in the community

    ✓ Peer-reviewed Risk factors Annals of neurology

    Key finding: Impaired odor identification, particularly in the anosmic range, is associated with increased mortality in older adults even after controlling for dementia and medical comorbidity. +2 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2015-07-03

    Dealing with behavioral and psychological symptoms of dementia: a general overview

    ✓ Peer-reviewed Prevention trials Psychology research and behavior management

    Key finding: Potential nonpharmacological interventions for BPSD are: cognitive training/stimulation, rehabilitative care, activities of daily living, music therapy, massage/touch, physical activity, education/training of professionals, and education and psychosocial support of informal caregivers. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2015-07-02

    Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

    ✓ Peer-reviewed Drug development Neuroscience

    Key finding: In addition, the GLP-1 mimetic exendin-4 has shown protective effects in animal models of Parkinson's disease (PD), and a clinical trial in PD patients showed promising first results. +2 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2015-07-02

    Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease

    ✓ Peer-reviewed Treatments Acta biomaterialia

    Key finding: Laser-scanning confocal microscopy, flow cytometry analysis and inductively coupled plasma-atomic emission spectroscopy ICP-AES revealed high cellular uptake of B6-SA-SeNPs by cerebral endothelial cells (bEnd.3). +2 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2015-07-02

    Nursing home and end-of-life care in Parkinson disease

    ✓ Peer-reviewed Disparities Neurology

    Key finding: A large proportion of the Medicare PD population resides in an LTCF. +1 more finding

    Full summary, score breakdown and related studies → Original source

  7. 2015-07-02

    Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue

    ✓ Peer-reviewed Brain scans and imaging Acta neuropathologica communications

    Key finding: Saturation and competition binding studies of (3)H-THK5117 in post-mortem AD brain tissue showed the presence of multiple binding sites. +1 more finding

    Full summary, score breakdown and related studies → Original source

  8. 2015-07-02

    When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients

    ✓ Peer-reviewed Getting a diagnosis Neurology

    Key finding: The diagnostic accuracy for MSA was suboptimal in this autopsy study. +2 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2015-07-02

    The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features

    ✓ Peer-reviewed Getting a diagnosis Brain : a journal of neurology

    Key finding: Patients with behavioural Alzheimer's disease showed worse memory scores than behavioural variant frontotemporal dementia and did not differ from typical Alzheimer's disease, while executive function composite scores were lower compared to behavioural variant frontotemporal dementia and typical Alzheimer's disease. +2 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2015-07-01

    DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study

    ✓ Peer-reviewed Treatments Alzheimer s & Dementia

    Key finding: We present the results of an analysis of observed data from a randomized, double-blind, placebo-controlled Phase 2b study. +3 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2015-07-01

    DT‐01‐03: Efficacy and safety of gantenerumab in prodromal Alzheimer's disease: Results from scarlet road—a global, multicenter trial

    ✓ Peer-reviewed Treatments Alzheimer s & Dementia

    Key finding: Biomarker results are presented separately. +2 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2015-07-01

    O4‐04‐05: Aducanumab (BIIB037), an anti‐amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer's disease: Interim results of a randomized, double‐blind, placebo‐controlled, phase 1b study

    ✓ Peer-reviewed Treatments Alzheimer s & Dementia

    Key finding: Interim analyses included: (1) subjects in all arms who completed the Week 26 visit, and (2) subjects in all arms who completed the Week 54 visit (results for placebo, 1, 3 and 10 mg/kg aducanumab at Week 54 available here, results for 6 mg/kg at Week 54 will be presented).

    Full summary, score breakdown and related studies → Original source

  13. 2015-07 month only

    [(18)F]Florbetaben: a review in β-amyloid PET imaging in cognitive impairment

    ✓ Peer-reviewed Brain scans and imaging CNS drugs

    Key finding: Visual assessment of regional and whole brain [(18)F]florbetaben PET images detected brain β-amyloid with high sensitivity and specificity, with good inter-reader agreement, in a phase III study in patients with various levels of cognitive function when compared with postmortem histopathological assessment.

    Full summary, score breakdown and related studies → Original source

  14. 2015-07-01

    Motor-Cognitive Dual-Task Training in Persons With Neurologic Disorders: A Systematic Review

    ✓ Peer-reviewed Digital health tools Journal of neurologic physical therapy : JNPT

    Key finding: The inclusion criteria of the studies reviewed limited the diagnostic groups included. +2 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2015-07-01

    Trajectory of Cognitive Decline After Incident Stroke

    ✓ Peer-reviewed Disparities JAMA

    Key finding: Incident stroke was associated with an acute decline in cognitive function and also accelerated and persistent cognitive decline over 6 years. +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2015-07-01

    The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease

    ✓ Peer-reviewed End-of-life care Drugs & aging

    Key finding: Based on the results of randomized controlled trials and several meta-analyses, ChEIs appear to show modest but statistically significant improvements on several measures, including cognition and global functioning. +2 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2015-07-01

    Protective Effects of Physical Exercise in Alzheimer's Disease and Parkinson's Disease: A Narrative Review

    ✓ Peer-reviewed Prevention trials Journal of clinical neurology (Seoul, Korea)

    Key finding: Research has shown that the neuroprotective mechanisms induced by PE are linked to an increased production of superoxide dismutase, endothelial nitric oxide synthase, brain-derived neurotrophic factor, nerve growth factor, insulin-like growth factor, and vascular endothelial growth factor, and a reduction in the production of free radicals in brain areas such as the hippocampus, which is particularly involved in memory.

    Full summary, score breakdown and related studies → Original source

  18. 2015-07-01

    The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015

    ✓ Peer-reviewed Brain scans and imaging Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The PET Core has demonstrated a variety of methods for the standardization of biomarkers such as florbetapir PET in a multicenter setting. +3 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2015-07-01

    Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans

    ✓ Peer-reviewed Genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Numerous genetic susceptibility and protective markers for AD and disease biomarkers have been identified and replicated using ADNI data and have heavily implicated immune, mitochondrial, cell cycle/fate, and other biological processes. +1 more finding

    Full summary, score breakdown and related studies → Original source

  20. 2015-07-01

    Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Plans for the next phase of the ADNI project include maintaining longitudinal follow-up of the normal and mild cognitive impairment cohorts, augmenting specific clinical cohorts, and incorporating novel computerized cognitive assessments and patient-reported outcomes.

    Full summary, score breakdown and related studies → Original source

  21. 2015-07-01

    The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Further studies will refine this model and enable the use of biomarkers studied in ADNI clinically and in disease-modifying therapeutic trials. +1 more finding

    Full summary, score breakdown and related studies → Original source

  22. 2015-07-01

    Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease

    ✓ Peer-reviewed Hippocampus size on brain scans The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: The FDG-positive subgroup showed only hypometabolism, predominantly in AD-sensitive areas extending to the whole neocortex, compared with the FDG-negative subgroup. +4 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2015-07-01

    Availability and Primary Health Care Orientation of Dementia-Related Services in Rural Saskatchewan, Canada

    ✓ Peer-reviewed End-of-life care Home health care services quarterly

    Key finding: Data were collected from 71 rural Home Care Assessors via cross-sectional survey. +4 more findings

    Full summary, score breakdown and related studies → Original source

  24. 2015-07-01

    Place of Death: Trends Over the Course of a Decade: A Population-Based Study of Death Certificates From the Years 2001 and 2011

    ✓ Peer-reviewed End-of-life care Deutsches Arzteblatt international

    Key finding: Most people in Germany die in institutions; the most common place of death is still the hospital, where more than half of all deaths take place. +1 more finding

    Full summary, score breakdown and related studies → Original source

  25. 2015-07-01

    Tools to Promote Shared Decision Making in Serious Illness: A Systematic Review

    ✓ Peer-reviewed End-of-life care JAMA internal medicine

    Key finding: Seventeen randomized clinical trials tested decision tools in serious illness. +1 more finding

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →